文献速递医学教育与科研方法流行病学与生物统计

新冠疫情及之后非洲背景下的临床试验注册:我们学到了什么?

Clinical trial registration during COVID-19 and beyond in the African context: what have we learned?
PubMed 文献 · Trials · 2022-06-06

文章指出新冠疫情暴发后非洲大陆面临多种贫困相关疾病负担,临床研究为治疗和预防提供了希望;全球大量新冠临床试验中,非洲仅三个国家占该大陆注册试验的80%以上,显示非洲新冠研究的地理差异。文章从临床试验注册视角强调研究透明度和数据可及性对知情决策的重要性,并总结注册有助于追踪方案变更、减少发表偏倚、促进合作和结果共享。

要点

  • 非洲仅三个国家占该大陆新冠注册试验的80%以上,显示地理差异。
  • 临床试验注册有助于追踪方案变更并减少发表偏倚。
  • 注册是发表的条件,并使试验摘要结果可公开获取。

核心结论

  • 新冠疫情期间的关键教训是临床试验注册对于促进追踪方案变更和减少发表偏倚很重要,从而促进和倡导临床研究透明度。

研究设计与样本

  • 本文为视角性文章,讨论非洲背景下新冠临床试验注册的经验与教训。

主要发现

  • 全球开展大量新冠临床试验,但非洲仅三个国家占该大陆在临床试验注册平台注册试验的80%以上。
  • 临床试验注册平台可作为计划中、进行中和已完成试验的来源,并允许高效分配资金以避免重复研究。
  • 临床试验注册有助于识别研究空白,为研究人员之间的合作提供机会。

关键数值与推荐

  • 临床试验注册是发表的条件,并使试验摘要结果可公开获取。
  • 遵守结果共享原则对快速增长的临床研究活动尤为重要。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Since the outbreak of COVID-19, many lives have been impacted especially on the African continent which is already fighting the burden of multiple diseases of poverty. However, clinical research has offered hope for treatment and prevention options for this infectious disease. Despite many COVID-19 clinical trials conducted globally, three countries in Africa account for more than 80% of all trials from the continent registered trials in clinical trial registries. This indicates geographic disparity among COVID-19 research in Africa. From the perspective of clinical trial registration, transparency in clinical research and the availability of data became important for making informed decisions to manage the pandemic. Registries serve as a source of planned, ongoing, and completed trials while allowing efficient funding allocation for research that would not duplicate efforts. Additionally, research gaps can be identified, which provide opportunities for collaboration among researchers. Therefore, a critical lesson learnt during this pandemic is that clinical trial registration is important in facilitating the process of tracking changes made to protocols and minimizing publication bias, thereby promoting and advocating for clinical research transparency. Moreover, registration in a clinical trial registry is a condition for publication and allows for trial summary results to be publicly available. Adhering to the principle of results sharing is especially important for the rapidly growing clinical research activities racing to find evidence-based interventions to end the COVID-19 pandemic.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Mathebula L, Runeyi S, Wiysonge C, et al. Clinical trial registration during COVID-19 and beyond in the African context: what have we learned? Trials. 2022. PMID: 35668437. doi:10.1186/s13063-022-06412-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。